Source author record

Agnes Meyder

Agnes Meyder appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
2topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Peptide conformational sampling using the Quantum Approximate Optimization Algorithm

Protein folding -- the problem of predicting the spatial structure of a protein given its sequence of amino-acids -- has attracted considerable research effort in biochemistry in recent decades. In this work, we explore the potential of quantum computing to solve a simplified version of protein folding. More precisely, we numerically investigate the performance of a variational quantum algorithm, the Quantum Approximate Optimization Algorithm (QAOA), in sampling low-energy conformations of short peptides. We start by benchmarking the algorithm on an even simpler problem: sampling self-avoiding walks, which is a necessary condition for a valid protein conformation. Motivated by promising results achieved by QAOA on this problem, we then apply the algorithm to a more complete version of protein folding, including a simplified physical potential. In this case, based on numerical simulations on 20 qubits, we find less promising results: deep quantum circuits are required to achieve accurate results, and the performance of QAOA can be matched by random sampling up to a small overhead. Overall, these results cast serious doubt on the ability of QAOA to address the protein folding problem in the near term, even in an extremely simplified setting. We believe that the approach and conclusions presented in this work could offer valuable methodological insights on how to systematically evaluate variational quantum optimization algorithms on real-world problems beyond protein folding.

preprint2022arXiv

The prospects of Monte Carlo antibody loop modelling on a fault-tolerant quantum computer

Quantum computing for the biological sciences is an area of rapidly growing interest, but specific industrial applications remain elusive. Quantum Markov chain Monte Carlo has been proposed as a method for accelerating a broad class of computational problems, including problems of pharmaceutical interest. Here we investigate the prospects of quantum advantage via this approach, by applying it to the problem of modelling antibody structure, a crucial task in drug development. To minimize the resources required while maintaining pharmaceutical-level accuracy, we propose a specific encoding of molecular dihedral angles into registers of qubits and a method for implementing, in quantum superposition, a Markov chain Monte Carlo update step based on a classical all-atom force field. We give the first detailed analysis of the resources required to solve a problem of industrial size and relevance and find that, though the time and space requirements of using a quantum computer in this way are considerable, continued technological improvements could bring the required resources within reach in the future.

preprint2021arXiv

Quantum Computational Quantification of Protein-Ligand Interactions

We have demonstrated a prototypical hybrid classical and quantum computational workflow for the quantification of protein-ligand interactions. The workflow combines the Density Matrix Embedding Theory (DMET) embedding procedure with the Variational Quantum Eigensolver (VQE) approach for finding molecular electronic ground states. A series of $β$-secretase (BACE1) inhibitors is rank-ordered using binding energy differences calculated on the latest superconducting transmon (IBM) and trapped-ion (Honeywell) Noisy Intermediate Scale Quantum (NISQ) devices. This is the first application of real quantum computers to the calculation of protein-ligand binding energies. The results shed light on hardware and software requirements which would enable the application of NISQ algorithms in drug design.